Exhibit 99.1
Contact Martin J. Landon - Investors
KCI
(210) 255-6494
Elliot Sloane - Media
Sloane & Company
(212) 446-1860
KINETIC CONCEPTS REPORTS
SECOND QUARTER AND SIX MONTH
FINANCIAL RESULTS FOR 2004
San Antonio, Texas, August 3, 2004 - Kinetic Concepts, Inc. (NYSE: KCI) today reported second quarter 2004 net revenue of $237.0 million, an increase of 30% from second quarter 2003 revenue of $182.9 million. Net revenue for the first half of 2004 was $461.8 million, representing a 32% increase from the same period a year ago. Foreign currency exchange movements favorably impacted net revenue for the second quarter and first half of 2004 by 2% and 3%, respectively, over the corresponding periods of the prior year.
Net earnings for the second quarter of 2004 were $24.0 million, including after-tax expenses of $3.6 million associated with a follow-on stock offering, compared to net earnings of $19.0 million for the same period one year ago. For the first six months of 2004, net earnings were $29.5 million. Net loss available to stockholders for the first six months of 2004 was $36.1 million, after recognition of $65.6 million of preferred stock dividends in connection with the IPO. Earnings per diluted share for the second quarter of 2004 were $0.34, compared to earnings per diluted share of $0.25 for the same period in the prior year. For the first half of 2004, the Company reported a net loss per diluted share, after dividends, of $0.63, compared to net earnings per diluted share of $0.47 for the prior year period.
Non-GAAP Financial Information(1)
On February 27, 2004, KCI completed an initial public offering ("IPO") of common stock. A total of 20.7 million shares of KCI common stock were sold in the IPO, including 3.5 million newly-issued shares. Upon the closing of the IPO, the Company accelerated recognition of in-kind preferred stock dividends and converted all outstanding shares of preferred stock into 19.2 million shares of common stock. On June 16, 2004, KCI completed a follow-on secondary stock offering of 16.1 million previously-issued common shares. These transactions had the effect of reducing net earnings for the second quarter by $3.6 million, or $0.05 per diluted share. Excluding expenses associated with the stock offerings and debt prepayments, net earnings for the 2004 second quarter of $27.6 million, were up 45% from the same period a year ago. Earnings per diluted share, excluding expenses associated with the stock offerings and debt prepayments, were $0.39 in the quarter compared to $0.25 in 2003, a 56% improvement over the prior year. Net earnings for the first half of 2004, excluding expenses and preferred stock dividends associated with the stock offerings and debt prepayments, were $51.1 million, up 42% from net earnings of $35.9 million for the same period a year ago. Net earnings per diluted share, excluding expenses and dividends associated with the KCI stock offerings and debt prepayments, were $0.73 in the first six months of 2004 compared to $0.47, an increase of 55% from the prior year.
(1)Throughout this press release, we have presented income statement items on a non-GAAP basis to exclude the impact of expenses and the acceleration of the in-kind preferred stock dividends incurred as result of the stock offerings and debt prepayments. These non-GAAP financial measures do not replace the presentation of our GAAP financial results. We have provided this supplemental non-GAAP information because it provides meaningful information regarding our results on a basis that better facilitates comparisons between the periods presented. Management uses this non-GAAP financial information, along with other GAAP information, for reviewing the operating results of its business segments and for analyzing potential future business trends. In addition, we believe investors may use the information in a similar fashion. A reconciliation of our GAAP income statement for the periods presented to the non-GAAP financial information provided is included herein. See the attached Reconciliation of Condensed Consolidated Statement of Earnings.
"We continue to execute on our strategic plan with programs aimed at increasing awareness of the benefits of V.A.C. therapy," noted Dennert O. Ware, president and chief executive officer of KCI. "The many physician presentations concerning negative pressure wound therapy made at the recent World Union of Wound Healing Societies held in Paris bolsters our confidence that we are on the right track and we look forward to a good second half of 2004."
Revenue Recap
Domestic revenue was $179.6 million for the second quarter and $349.6 million for the first half of 2004, representing increases of 30% and 32%, respectively, due primarily to increased demand for V.A.C. wound healing devices and related disposables. International revenue of $57.3 million for the second quarter and $112.2 million for the first six months of 2004 increased 28% and 33%, respectively, compared to the prior year, as a result of increased V.A.C. demand and favorable foreign currency exchange movements. Foreign currency exchange movements favorably impacted international revenue by 8% and 13%, respectively, compared to the second quarter and first six months of the prior year.
Worldwide V.A.C. revenue was $166.5 million for the second quarter of 2004, an increase of 47% from the prior-year period, while worldwide V.A.C. revenue for the first half of 2004 grew 49% to $314.8 million. Excluding the effects of foreign currency exchange movements, worldwide V.A.C. revenue for the second quarter and first six months of 2004 increased 45% and 46%, respectively, from the prior year. The growth in V.A.C. was bolstered by increased physician and payer awareness of the benefits of V.A.C. therapy and increased product adoption across wound types.
Worldwide surface revenue was $70.5 million for the second quarter and $147.0 million for the first half of 2004, representing increases of 2% and 6%, respectively, from the corresponding periods in the prior year. Favorable currency exchange rate movements accounted for the majority of the second quarter 2004 surface revenue increase as higher rental revenue, resulting from favorable product mix changes, was offset by lower sales of therapeutic surfaces. For the first six months, foreign currency exchange movements accounted for half of the worldwide surfaces revenue increase compared to the prior year. Higher bariatric surfaces revenue for the first half was partially offset by lower wound care surfaces sales, accounting for the remainder of the surfaces revenue increase.
Income Tax Rate
The effective tax rate for the second quarter and first half of 2004 was 36% compared to 37.5% for the same periods a year ago. The income tax rate reduction is primarily attributable to a higher proportion of taxable income in lower tax jurisdictions.
Liquidity
As of June 30, 2004, KCI had $499.7 million of total debt (long-term debt and capital lease obligations outstanding). During the quarter, the Company redeemed $34.3 million of its 7 3/8% Senior Subordinated Notes due 2013, and paid down an additional $30.0 million under the senior credit facility. Total debt prepayments made in the first half of 2004 were $186.1 million. Total cash at June 30, 2004 was $75.5 million.
Outlook
The following guidance is based on current information and expectations as of August 3, 2004.
| | Full Year 2004 |
| | | | Forecast |
| | Forecast | | (As Adjusted) (1) |
Revenue | | $950 - $980 million | | $950 - $980 million |
Net Earnings | | $82 - $88 million | | $104 - $110 million |
EPS | | $0.24 - $0.33 | | $1.48 - $1.54 |
Diluted Shares | | 67.5 - 68.5 million (2) | | 70.5 - 71.5 million |
(1) "As adjusted" forecast information is non-GAAP and excludes approximately $21.6 million of expenses
and $65.6 million of preferred stock dividends associated with the Company's public stock offerings
and debt prepayments.
(2) Due to their antidilutive effect, 2,990,089 dilutive potential common shares from preferred stock
conversion have been excluded from the diluted weighted average shares calculation.
Earnings Release Conference Call
As previously announced, the Company has scheduled an earnings release conference call for 8:30 a.m. eastern daylight time today, Tuesday, August 3, 2004. The dial-in numbers for this conference call are as follows:
Domestic Dial-in Number: 800-599-9829
International Dial-in Number: +617-847-8703
Participant Code: 49054465
This call is being web cast by CCBN and can be accessed at the Kinetic Concepts, Inc. Web site at
http://www.kci1.com/investor/index.asp, and clicking onWeb cast - Q2 2004 Kinetic Concepts Earnings Call. The web cast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center atwww.fulldisclosure.com and institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). An archive of the Web cast will be available athttp://www.kci1.com/investor/index.asp until August 2, 2005.
KCI's business outlook as of today is expected to be available on KCI's Investor Relations Web site. It is currently expected that the full business outlook will not be updated until the release of KCI's next quarterly earnings announcement, notwithstanding subsequent developments. However, although KCI undertakes no duty to update its business outlook, KCI may update the full business outlook or any portion thereof at any time.
About KCI
Kinetic Concepts, Inc. is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces. We design, manufacture, market and service a wide range of proprietary products that can significantly improve clinical outcomes while reducing the overall cost of patient care by accelerating the healing process or preventing complications. Our advanced wound care systems incorporate our proprietary Vacuum Assisted Closureâ , or V.A.C.â , technology, which has been clinically demonstrated to promote wound healing and reduce the cost of treating patients with serious wounds. Our therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address complications associated with immobility and obesity, such as pressure sores and pneumonia. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings including acute care hospitals, extended care facilities and patients' homes both in the United States and abroad.
Forward-Looking Statements
This press release contains forward-looking statements including, among other things, management's estimates of future performance, revenue and earnings, our management's growth objectives and our management's ability to produce consistent operating improvements. The forward-looking statements contained herein are based on our current expectations and are subject to a number of risks and uncertainties which could cause us to fail to achieve our current financial projections and other expectations, such as a change in the demand for the V.A.C. resulting from increased competition, a change in payer reimbursement policies, our ability to protect our intellectual property rights and general economic conditions. All information set forth in this release and its attachments is as of August 3, 2004. We undertake no duty to update this information. More information about potential factors that could affect our business and financial results is included in our Annual Report on form 10- K for the fiscal year ended December 31, 2003, including, among other sections, under the captions, "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations," which is on file with the SEC and available at the SEC's website atwww.sec.gov. Additional information will also be set forth in those sections in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2004, which will be filed with the SEC in the third quarter of 2004.
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Condensed Consolidated Statement of Earnings |
(in thousands, except per share data) |
(unaudited) |
| | |
| | |
| Three months ended June 30, | Six months ended June 30, |
| | | % | | | | % |
| 2004 | 2003 | Change | 2004 | | 2003 | Change |
Revenue: | | | | | | | |
Rental | $ 175,579 | $140,854 | 24.7 % | $ 341,487 | | $ 270,296 | 26.3 % |
Sales | 61,406 | 42,023 | 46.1 | 120,332 | | 79,584 | 51.2 |
| _______ | _______ | | _______ | | _______ | |
Total revenue | 236,985 | 182,877 | 29.6 | 461,819 | | 349,880 | 32.0 |
| _______ | _______ | | _______ | | _______ | |
Rental expenses | 109,572 | 87,911 | 24.6 | 214,978 | | 167,290 | 28.5 |
Cost of goods sold | 16,560 | 14,713 | 12.6 | 33,328 | | 28,358 | 17.5 |
| _______ | _______ | | _______ | | _______ | |
Gross profit | 110,853 | 80,253 | 38.1 | 213,513 | | 154,232 | 38.4 |
| | | | | | | |
Selling, general and administrative expenses | 52,898 | 40,050 | 32.1 | 101,440 | | 76,531 | 32.5 |
Research and development expenses | 7,188 | 4,439 | 61.9 | 14,307 | | 8,864 | 61.4 |
Initial public offering expenses | 302 | - | - | 19,836 | | - | - |
Secondary offering expenses | 2,219 | - | - | 2,219 | | - | - |
| _______ | _______ | | _______ | | _______ | |
Operating earnings | 48,246 | 35,764 | 34.9 | 75,711 | | 68,837 | 10.0 |
| _______ | _______ | | _______ | | _______ | |
Interest income | 158 | 347 | (54.5) | 529 | | 747 | (29.2) |
Interest expense | (11,050) | (8,050) | (37.3) | (29,894) | | (16,228) | (84.2) |
Foreign currency gain (loss) | 201 | 2,368 | (91.5) | (263) | | 4,156 | (106.3) |
| _______ | _______ | | _______ | | _______ | |
Earnings before income taxes | 37,555 | 30,429 | 23.4 | 46,083 | | 57,512 | (19.9) |
Income taxes | 13,520 | 11,411 | 18.5 | 16,590 | | 21,567 | (23.1) |
| _______ | _______ | | _______ | | _______ | |
Net earnings | $ 24,035 | $ 19,018 | 26.4 % | $ 29,493 | | $ 35,945 | (17.9) % |
Series A convertible preferred stock dividends | - | - | - | (65,604) | | - | - |
| _______ | _______ | | _______ | | _______ | |
Net earnings (loss) available to | | | | | | | |
common shareholders | $ 24,035 | $ 19,018 | 26.4 % | $ (36,111) | | $ 35,945 | (200.5) % |
| _______ | _______ | | _______ | | _______ | |
Net earnings (loss) per share available | | | | | | | |
to common shareholders: | | | | | | | |
Basic | $ 0.37 | $ 0.27 | 37.0 % | $ (0.63) | | $ 0.51 | (223.5) % |
| _______ | _______ | | _______ | | _______ | |
Diluted | $ 0.34 | $ 0.25 | 36.0 % | $ (0.63) | | $ 0.47 | (234.0) % |
| _______ | _______ | | _______ | | _______ | |
Weighted average shares outstanding: | | | | | | | |
Basic | 65,087 | 71,070 | | 57,709 | | 71,032 | |
| _______ | _______ | | _______ | | _______ | |
Diluted | 71,303 | 77,236 | | 57,709 | (1) | 76,904 | |
| _______ | _______ | | _______ | | _______ | |
| | | | | | | |
(1) Due to their antidilutive effect, 6,128 dilutive potential common shares from stock options and 6,013 dilutive potential common
shares from preferred stock conversion have been excluded from the diluted weighted average shares calculation for the six months
ended June 30, 2004.
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Reconciliation of Condensed Consolidated Statement of Earnings (1) |
For the Three Months ended June 30, |
(in thousands, except per share data) |
(unaudited) |
|
|
| 2004 |
| | | Excluding | | |
| | Costs and | Costs and | | |
| | Expenses Related | Expenses Related | | |
| | to Offerings and | to Offerings and | | |
| | Debt Prepayments | Debt Prepayments | GAAP | % |
| GAAP | (non-GAAP) | (non-GAAP) | 2003 | Change (2) |
Revenue: | | | | | |
Rental | $ 175,579 | $ - | $ 175,579 | $ 140,854 | 24.7 % |
Sales | 61,406 | - | 61,406 | 42,023 | 46.1 |
| _______ | _______ | _______ | _______ | |
Total revenue | 236,985 | - | 236,985 | 182,877 | 29.6 |
| _______ | _______ | _______ | _______ | |
Rental expenses | 109,572 | - | 109,572 | 87,911 | 24.6 |
Cost of goods sold | 16,560 | - | 16,560 | 14,713 | 12.6 |
| _______ | _______ | _______ | _______ | |
Gross profit | 110,853 | - | 110,853 | 80,253 | 38.1 |
| | | | | |
Selling, general and administrative expenses | 52,898 | - | 52,898 | 40,050 | 32.1 |
Research and development expenses | 7,188 | - | 7,188 | 4,439 | 61.9 |
Initial public offering expenses | 302 | (302) | - | - | - |
Secondary offering expenses | 2,219 | (2,219) | - | - | - |
| _______ | _______ | _______ | _______ | |
Operating earnings | 48,246 | 2,521 | 50,767 | 35,764 | 42.0 |
| _______ | _______ | _______ | _______ | |
Interest income | 158 | - | 158 | 347 | (54.5) |
Interest expense | (11,050) | 3,055 | (7,995) | (8,050) | 0.7 |
Foreign currency gain | 201 | - | 201 | 2,368 | (91.5) |
| _______ | _______ | _______ | _______ | |
Earnings before income taxes | 37,555 | 5,576 | 43,131 | 30,429 | 41.7 |
Income taxes | 13,520 | 2,008 | 15,528 | 11,411 | 36.1 |
| _______ | _______ | _______ | _______ | |
Net earnings | $ 24,035 | $ 3,568 | $ 27,603 | $ 19,018 | 45.1 % |
| _______ | _______ | _______ | _______ | |
Net earnings per share: | | | | | |
Basic | $ 0.37 | | $ 0.42 | $ 0.27 | 55.6 % |
| _______ | | _______ | _______ | |
Diluted | $ 0.34 | | $ 0.39 | $ 0.25 | 56.0 % |
| _______ | | _______ | _______ | |
Weighted average shares outstanding: | | | | | |
Basic | 65,087 | | 65,087 | 71,070 | |
| _______ | | _______ | _______ | |
Diluted | 71,303 | | 71,303 | 77,236 | |
| _______ | | _______ | _______ | |
| | | | | |
(1) These adjusted non-GAAP financial measures should be read in conjunction with our GAAP financial results. See footnote 1 on page 1
of this press release for further discussion of our non-GAAP financial information.
(2) Percentage change reflects the percentage variance between the 2004 (non-GAAP) results, excluding offering and debt prepayment
related costs and expenses, and the 2003 GAAP results.
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Reconciliation of Condensed Consolidated Statement of Earnings (1) |
For the Six Months ended June 30, |
(in thousands, except per share data) |
(unaudited) |
|
|
| 2004 |
| | Costs and | Excluding | | |
| | Expenses | Costs and | | |
| | Related to | Expenses Related | | |
| | Offerings | to Offerings | | |
| | and Debt | and Debt | | |
| | Prepayments | Prepayments | GAAP | % |
| GAAP | (non-GAAP) | (non-GAAP) | 2003 | Change (2) |
Revenue: | | | | | |
Rental | $ 341,487 | $ - | $ 341,487 | $ 270,296 | 26.3 % |
Sales | 120,332 | - | 120,332 | 79,584 | 51.2 |
| _______ | _______ | _______ | _______ | |
Total revenue | 461,819 | - | 461,819 | 349,880 | 32.0 |
| _______ | _______ | _______ | _______ | |
Rental expenses | 214,978 | - | 214,978 | 167,290 | 28.5 |
Cost of goods sold | 33,328 | - | 33,328 | 28,358 | 17.5 |
| _______ | _______ | _______ | _______ | |
Gross profit | 213,513 | - | 213,513 | 154,232 | 38.4 |
| | | | | |
Selling, general and administrative expenses | 101,440 | - | 101,440 | 76,531 | 32.5 |
Research and development expenses | 14,307 | - | 14,307 | 8,864 | 61.4 |
Initial public offering expenses | 19,836 | (19,836) | - | - | - |
Secondary offering expenses | 2,219 | (2,219) | - | - | - |
| _______ | _______ | _______ | _______ | |
Operating earnings | 75,711 | 22,055 | 97,766 | 68,837 | 42.0 |
| _______ | _______ | _______ | _______ | |
Interest income | 529 | - | 529 | 747 | (29.2) |
Interest expense | (29,894) | 11,689 | (18,205) | (16,228) | (12.2) |
Foreign currency gain (loss) | (263) | - | (263) | 4,156 | (106.3) |
| _______ | _______ | _______ | _______ | |
Earnings before income taxes | 46,083 | 33,744 | 79,827 | 57,512 | 38.8 |
Income taxes | 16,590 | 12,148 | 28,738 | 21,567 | 33.2 |
| _______ | _______ | _______ | _______ | |
Net earnings | $ 29,493 | $ 21,596 | $ 51,089 | $ 35,945 | 42.1 % |
Series A convertible preferred stock dividends | (65,604) | 65,604 | - | - | - |
| _______ | _______ | _______ | _______ | |
Net earnings (loss) available to | | | | | |
common shareholders | $ (36,111) | $ 87,200 | $ 51,089 | $ 35,945 | 42.1 % |
| _______ | _______ | _______ | _______ | |
Net earnings (loss) per share available | | | | | |
to common shareholders: | | | | | |
Basic | $ (0.63) | | $ 0.89 | $ 0.51 | 74.5 % |
| _______ | | _______ | _______ | |
Diluted | $ (0.63) | | $ 0.73 | $ 0.47 | 55.3 % |
| _______ | | _______ | _______ | |
Weighted average shares outstanding: | | | | | |
Basic | 57,709 | | 57,709 | 71,032 | |
| _______ | | _______ | _______ | |
Diluted | 57,709 | (3) | 69,850 | 76,904 | |
| _______ | | _______ | _______ | |
| | | | | |
(1) These adjusted non-GAAP financial measures should be read in conjunction with our GAAP financial results. See footnote 1 on page 1
of this press release for further discussion of our non-GAAP financial information.
(2) Percentage change reflects the percentage variance between the 2004 (non-GAAP) results, excluding offering and debt prepayment
related costs and expenses, and the 2003 GAAP results.
(3) Due to their antidilutive effect, 6,128 dilutive potential common shares from stock options and 6,013 dilutive potential common shares
from preferred stock conversion have been excluded from the diluted weighted average shares calculation for the six months ended
June 30, 2004.
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Condensed Consolidated Balance Sheets |
(in thousands) |
| | | |
| | | |
| June 30, | | December 31, |
| 2004 | | 2003 |
| (unaudited) | | |
Assets: | | | |
Current assets: | | | |
Cash and cash equivalents | $ 75,493 | | $ 156,064 |
Accounts receivable, net | 214,556 | | 199,938 |
Inventories, net | 30,823 | | 32,253 |
Deferred income taxes | 24,095 | | 22,749 |
Derivative financial instruments | 1,282 | | - |
Prepaid expenses and other current assets | 15,793 | | 11,811 |
| _______ | | _______ |
Total current assets | 362,042 | | 422,815 |
| _______ | | _______ |
| | | |
Net property, plant and equipment | 162,913 | | 145,208 |
Loan and preferred stock issuance costs, less accumulated amortization | | | |
of $3,248 in 2004 and $1,014 in 2003 | 13,273 | | 19,779 |
Goodwill | 48,791 | | 48,797 |
Other assets, less accumulated amortization of $8,530 in 2004 and | | | |
$8,190 in 2003 | 29,214 | | 28,497 |
| _______ | | _______ |
| $ 616,233 | | $ 665,096 |
| _______ | | _______ |
Liabilities and Shareholders' Deficit: | | | |
Current liabilities: | | | |
Accounts payable | $ 33,594 | | $ 34,386 |
Accrued expenses | 122,275 | | 112,652 |
Current installments of long-term debt | 4,166 | | 4,800 |
Current installments of capital lease obligations | 1,504 | | 1,576 |
Derivative financial instruments | - | | 2,402 |
Income taxes payable | - | | 39,403 |
| _______ | | _______ |
Total current liabilities | 161,539 | | 195,219 |
| _______ | | _______ |
| | | |
Long-term debt, net of current installments | 492,682 | | 678,100 |
Capital lease obligations, net of current installments | 1,298 | | 1,351 |
Deferred income taxes, net | 29,248 | | 26,566 |
Deferred gain, sale of headquarters facility | 8,647 | | 9,183 |
Other non-current liabilities | 213 | | 212 |
| _______ | | _______ |
| 693,627 | | 910,631 |
Series A convertible preferred stock, 0 issued and outstanding | | | |
at June 30, 2004 and 264 at December 31, 2003 | - | | 261,719 |
| | | |
Shareholders' equity (deficit): | | | |
Common stock; authorized 225,000 at June 30, 2004 and | | | |
150,000 at December 31, 2003; issued and outstanding 66,654 | | | |
at June 30, 2004 and 41,270 at December 31, 2003 | 67 | | 41 |
Additional paid-in capital | 468,479 | | 1,157 |
Deferred compensation | (1,515) | | 185 |
Retained deficit | (555,066) | | (518,955) |
Accumulated other comprehensive income | 10,641 | | 10,318 |
| _______ | | _______ |
Shareholders' deficit | (77,394) | | (507,254) |
| _______ | | _______ |
| $ 616,233 | | $ 665,096 |
| _______ | | _______ |
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
Condensed Consolidated Statements of Cash Flows |
(in thousands) |
(unaudited) |
| |
| |
| Six months ended June 30, |
| 2004 | | 2003 |
Cash flows from operating activities: | | | |
Net earnings | $ 29,493 | | $ 35,945 |
Adjustments to reconcile net earnings to net cash provided by operating activities: | | | |
Depreciation and amortization | 27,763 | | 21,991 |
Provision for uncollectible accounts receivable | 6,053 | | 3,527 |
Amortization of deferred gain on sale of headquarters facility | (535) | | (521) |
Write-off of deferred loan fees | 4,534 | | - |
Non-cash amortization of stock award to directors | 114 | | - |
Tax benefit related to exercise of stock options | 30,177 | | - |
Change in assets and liabilities: | | | |
Increase in accounts receivable, net | (20,741) | | (10,342) |
Decrease (increase) in other accounts receivable | (784) | | 175,000 |
Decrease in current deferred income taxes | (1,346) | | (66,838) |
Decrease in inventories | 1,406 | | 4,148 |
Increase in prepaid expenses and other current assets | (3,981) | | (1,979) |
Increase (decrease) in accounts payable | (800) | | 1,218 |
Increase in accrued expenses | 15,945 | | 18,100 |
Increase (decrease) in income taxes payable | (39,403) | | 20,282 |
Increase (decrease) in deferred income taxes, net | 1,580 | | (1,826) |
Net cash provided by operating activities | 49,475 | | 198,705 |
| _______ | | _______ |
Cash flows from investing activities: | | | |
Additions to property, plant and equipment | (42,376) | | (34,381) |
Increase in inventory to be converted into equipment for short-term rental | (4,800) | | (1,300) |
Dispositions of property, plant and equipment | 1,293 | | 634 |
Business acquisitions, net of cash acquired | - | | (2,224) |
Increase in other assets | (264) | | (425) |
Net cash used by investing activities | (46,147) | | (37,696) |
| _______ | | _______ |
Cash flows from financing activities: | | | |
Repayment of notes payable, long term, capital lease and other obligations | (186,177) | | (114,856) |
Initial public offering of common stock: | | | |
Proceeds from issuance of common stock | 105,000 | | - |
Stock issuance costs | (10,604) | | - |
Proceeds from exercise of stock options | 8,214 | | 846 |
| _______ | | _______ |
Net cash used by financing activities | (83,567) | | (114,010) |
| _______ | | _______ |
| | | |
Effect of exchange rate changes on cash and cash equivalents | (332) | | 1,489 |
| | | |
Net increase (decrease) in cash and cash equivalents | (80,571) | | 48,488 |
Cash and cash equivalents, beginning of period | 156,064 | | 54,485 |
Cash and cash equivalents, end of period | $ 75,493 | | $ 102,973 |
| _______ | | _______ |
Cash paid during the six months for: | | | |
Interest (1) | $ 25,431 | | $ 14,903 |
Income taxes | $ 28,283 | | $ 69,392 |
Non-cash activity: | | | |
Non-cash consideration for exercise of stock options | $ 6,354 | | $ - |
| | | |
(1) 2004 amount includes bond call premiums of $7.7 million related to the prepayments | | | |
on our 7 3/8% Senior Subordinated Notes due 2013. | | | |
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
SUPPLEMENTAL REVENUE DATA |
(unaudited) |
(in thousands) |
|
|
| �� Three months ended June 30, |
| | | | | | Variance |
| 2004 | | 2003 | | | $ | | % |
USA | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 101,447 | | $ 74,555 | | | $ 26,892 | | 36.1 | % |
Sales | 34,602 | | 19,855 | | | 14,747 | | 74.3 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 136,049 | | 94,410 | | | 41,639 | | 44.1 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 37,406 | | 36,373 | | | 1,033 | | 2.8 | |
Sales | 6,193 | | 7,260 | | | (1,067) | | (14.7) | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 43,599 | | 43,633 | | | (34) | | (0.1) | |
| | | | | | | | | |
Total USA rental | 138,853 | | 110,928 | | | 27,925 | | 25.2 | |
Total USA sales | 40,795 | | 27,115 | | | 13,680 | | 50.5 | |
| _______ | | _______ | | | ______ | | | |
Subtotal - USA | $ 179,648 | | $ 138,043 | | | $ 41,605 | | 30.1 | % |
| _______ | | _______ | | | ______ | | | |
International | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 15,413 | | $ 9,842 | | | $ 5,571 | | 56.6 | % |
Sales | 15,019 | | 9,181 | | | 5,838 | | 63.6 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 30,432 | | 19,023 | | | 11,409 | | 60.0 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 21,313 | | 20,084 | | | 1,229 | | 6.1 | |
Sales | 5,592 | | 5,727 | | | (135) | | (2.4) | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 26,905 | | 25,811 | | | 1,094 | | 4.2 | |
| | | | | | | | | |
Total International rental | 36,726 | | 29,926 | | | 6,800 | | 22.7 | |
Total International sales | 20,611 | | 14,908 | | | 5,703 | | 38.3 | |
| _______ | | _______ | | | ______ | | | |
Subtotal - International | $ 57,337 | | $ 44,834 | | | $ 12,503 | | 27.9 | % |
| _______ | | _______ | | | ______ | | | |
Total revenue | $ 236,985 | | $ 182,877 | | | $ 54,108 | | 29.6 | % |
| _______ | | _______ | | | ______ | | | |
KINETIC CONCEPTS, INC. AND SUBSIDIARIES |
SUPPLEMENTAL REVENUE DATA |
(unaudited) |
(in thousands) |
| |
| |
| Six months ended June 30, |
| | | | | | Variance |
| 2004 | | 2003 | | | $ | | % |
USA | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 191,354 | | $ 139,843 | | | $ 51,511 | | 36.8 | % |
Sales | 66,284 | | 36,947 | | | 29,337 | | 79.4 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 257,638 | | 176,790 | | | 80,848 | | 45.7 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 77,207 | | 74,235 | | | 2,972 | | 4.0 | |
Sales | 14,744 | | 14,646 | | | 98 | | 0.7 | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 91,951 | | 88,881 | | | 3,070 | | 3.5 | |
| | | | | | | | | |
Total USA rental | 268,561 | | 214,078 | | | 54,483 | | 25.5 | |
Total USA sales | 81,028 | | 51,593 | | | 29,435 | | 57.1 | |
| _______ | | _______ | | | ______ | | | |
Subtotal - USA | $ 349,589 | | $ 265,671 | | | $ 83,918 | | 31.6 | % |
| _______ | | _______ | | | ______ | | | |
International | | | | | | | | | |
V.A.C. | | | | | | | | | |
Rental | $ 28,787 | | $ 17,660 | | | $ 11,127 | | 63.0 | % |
Sales | 28,366 | | 17,187 | | | 11,179 | | 65.0 | |
| _______ | | _______ | | | ______ | | | |
Total V.A.C. | 57,153 | | 34,847 | | | 22,306 | | 64.0 | |
| | | | | | | | | |
Therapeutic surfaces/other | | | | | | | | | |
Rental | 44,139 | | 38,558 | | | 5,581 | | 14.5 | |
Sales | 10,938 | | 10,804 | | | 134 | | 1.2 | |
| _______ | | _______ | | | ______ | | | |
Total therapeutic surfaces/other | 55,077 | | 49,362 | | | 5,715 | | 11.6 | |
| | | | | | | | | |
Total International rental | 72,926 | | 56,218 | | | 16,708 | | 29.7 | |
Total International sales | 39,304 | | 27,991 | | | 11,313 | | 40.4 | |
| _______ | | _______ | | | ______ | | | |
Subtotal - International | $ 112,230 | | $ 84,209 | | | $ 28,021 | | 33.3 | % |
| _______ | | _______ | | | ______ | | | |
Total revenue | $ 461,819 | | $ 349,880 | | | $ 111,939 | | 32.0 | % |
| _______ | | _______ | | | ______ | | | |